Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-05-31
1991-11-05
Rivers, Diana G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514261, 514262, 544276, 544277, A61K 3152, C07D47318, C07D47334, C07D47316
Patent
active
050632337
ABSTRACT:
The compound of the formula I ##STR1## wherein R, R.sub.3 and R.sub.5 independently represent hydrogen or hydroxy provided that at least one of R, R.sub.3 and R.sub.5 represents hydroxy; R.sub.1 represents hydrogen, lower alkyl, C.sub.3 -C.sub.7 -alkenyl, hydroxy-lower alkyl, optionally substituted cycloalkyl or optionally substituted cycloalkyl-lower alkyl, bicycloalkyl, bicycloalkyl-lower alkyl, adamantyl, tetrahydropyranyl, tetrahydrothiopyranyl, tetrahydropyranyl-lower alkyl, tetrahydrothiopyranyl-lower alkyl, adamantyl-lower alkyl, aryl-hydroxy-lower alkyl, aryl, aryl-lower alkyl, aryl-C.sub.3 -C.sub.6 -cycloalkyl, 9-fluorenyl, 9-fluorenyl-lower alkyl or cycloalkenyl-lower alkyl; or R.sub.1 represents a bicyclic benzo-fused 5 or 6-membered saturated carbocyclic radical or a benz-fused 5 or 6-membered saturated heterocyclic radical containing a heteroatom selected from oxygen and sulfur directly attached to the fused benzene ring, any said bicyclic radicals being optionally substituted on the benzo portion by lower alkyl, lower alkoxy or halogen, or R.sub.1 represents any said bicyclic radical substituted-lower alkyl; R.sub.2 represents hydrogen, halogen, --S--R.sub.1 ', --NR.sub.b --R.sub.1 ', or --NH--R.sub.1 ' in each of which R.sub.1 ' has meaning as defined for R.sub.1 provided that R.sub.1 ' in --SR.sub.1 ' does not represent hydrogen; R.sub.b represents lower alkyl; R.sub.4 represents hydroxymethyl provided that R.sub.2 does not represent either hydrogen or --NHR.sub.1 ' in which R.sub.1 ' represents either hydrogen or lower alkyl; or R.sub.4 represents lower alkoxymethyl or lower alkylthiomethyl; or R.sub.4 represents --CONHR.sub.6 in which R.sub.6 represents lower alkyl, aryl-lower alkyl, C.sub.3 -C.sub.6 -cycloalkyl or hydroxy-lower alkyl; pharmaceutically acceptable ester derivatives thereof in which free hydroxy groups are esterified in form of a pharmaceutically acceptable ester; and pharmaceutically acceptable salts thereof; methods for their preparation; and their use as adenosine receptor agonists are disclosed.
REFERENCES:
patent: 3590029 (1971-06-01), Koch et al.
patent: 3752805 (1973-08-01), Maguire et al.
patent: 3825541 (1974-07-01), Vince
patent: 3838147 (1974-09-01), Pohlke et al.
patent: 3936439 (1976-02-01), Marumoto et al.
patent: 3968102 (1976-06-01), Suchiro et al.
patent: 3992531 (1976-11-01), Prasad et al.
patent: 4029884 (1977-06-01), Stein et al.
patent: 4104462 (1978-08-01), Fischer et al.
patent: 4138562 (1979-02-01), Vince
patent: 4167565 (1979-04-01), Stein et al.
patent: 4255565 (1981-03-01), Marumoto et al.
patent: 4258033 (1981-03-01), Marumoto et al.
patent: 4268672 (1981-05-01), Vince
patent: 4293690 (1981-10-01), Sawa et al.
patent: 4338310 (1982-07-01), Vince
patent: 4341769 (1982-07-01), Marumoto et al.
patent: 4362729 (1982-12-01), Vince
patent: 4383114 (1983-05-01), Vince
patent: 4501735 (1985-02-01), Trivedi et al.
patent: 4543255 (1985-09-01), Shealy et al.
patent: 4593019 (1986-06-01), Bristol et al.
patent: 4594350 (1986-06-01), Vince
patent: 4600707 (1986-07-01), Patt
patent: 4605659 (1986-08-01), Verheyden et al.
patent: 4683223 (1987-07-01), Trivedi
patent: 4728736 (1988-01-01), Shealy et al.
patent: 4740598 (1988-04-01), Nagabhushan et al.
patent: 4742064 (1988-05-01), Vince
patent: 4916224 (1990-04-01), Vince et al.
patent: 4954504 (1990-09-01), Chen et al.
patent: 4968674 (1990-11-01), Taniyama et al.
Shealy et al., J. Med. Chem., vol. 27 (11), pp. 1416-1421 (1984).
Montgomery, Accounts of Chemical Research, vol. 19 (10), pp. 293-300 (10/86).
Coward et al., Chemical Abstracts, vol. 79:87815x (1973).
Vince, Chemical Abstracts, vol. 96:181575s (1982).
Borchardt et al., Chemical Abstracts, vol. 84:53773v (1976).
Miyashita et al., Chemical Abstracts, vol. 106:84996x (1987), Abstract of Japan 85/215,685, 10/29/85.
Marquez et al., "Carbocyclic Nuceosides, Medicinal Research Reviews", vol. 6, No. 1, pp. 1-8, 11, 13-18, 37-40.
Madhauen et al., J. Org. Chem., vol. 51, pp. 1287-1293 (1986).
Shealy et al., J. Am. Chem., vol. 91, p. 3075 (1969).
Herdewijn et al., J. Med. Chem., vol. 28, p. 1385 (1985).
Shealy et al., J. Med. Chem., vol. 27, pp. 670-674 (1984).
Cormack et al., Tetrahedron Letters, vol. 1981, p. 2331 (1981).
Vince et al., J. Org. Chem., vol. 45, p. 531 (1980).
Paulsen et al., Chem. Ber., vol. 114, p. 346 (1981).
Marumoto et al., Chem. Pharm. Bull., vol. 24, p. 2624 (1976).
J. Pharmacology and Experimental Therapeutics, vol. 238, p. 954 (1986).
Marumoto et al., Chem. Abstracts, 105:126814y (1986).
Marumoto et al., Chem. Pharm. Bull., vol. 23, p. 758 (1975).
Daly et al., Biochemical Pharmacology, vol. 35, p. 2467 (1986).
Moos et al., J. Med., vol. 28, p. 1383 (1986).
Asahi Chemical Industry, Chem. Abstractsm vol. 94: 140119m (1981).
Kikugawa et al., Chem. Abstract, vol. 84:31369r (1976).
Kikugawa et al., Chem. Abstr., vol. 84:74578a (1976).
Chem. Abstr., vol. 85:177889c (1976).
Montgomery et al., Biol. Methylation Drug Res. (Proc. Symp. 1985), pp. 409-416 (1986).
Lizotte et al., Chem. Abstr., 99:139657g (1983).
Mihelich et al., Chem. Abstr., 98:125739c (1983).
Omura et al., Chem. Pharm. Bull., vol. 29, No. 7, pp. 1870-1875 (1981).
Hamilton et al., Life Sciences, vol. 41, pp. 2295-2302 (1987).
Marumoto et al., Chem. Pharma. Bull., vol. 23, pp. 759-774 (1975).
Marumoto et al., Takeda Res. Labs., vol. 44, pp. 220-230 (1985).
CA 84:74378a (1976), Kikugawa et al.
R. N. Prasad et al., J. Med. Chem., vol. 23, pp. 313-319 (1980).
R. F. Bruns, Can J. Physio Pharmacol., vol. 58, pp. 673-691 (1980).
Chen Jen
Hutchison Alan J.
Ciba-Geigy Corporation
Gruenfeld Norbert
Rivers Diana G.
LandOfFree
N.sub.9 -cyclopentyl-substituted adenine derivatives useful as a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N.sub.9 -cyclopentyl-substituted adenine derivatives useful as a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N.sub.9 -cyclopentyl-substituted adenine derivatives useful as a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499539